Valuation: CV Sciences, Inc.

Market Cap 4.47M 3.93M 3.65M 3.36M 6.3M 433M 6.41M 43.64M 17.02M 211M 16.77M 16.41M 732M P/E 2024
-2.48x
P/E 2025 -11.8x
Enterprise Value 6.19M 5.44M 5.05M 4.65M 8.72M 599M 8.87M 60.43M 23.57M 292M 23.22M 22.72M 1.01B EV / Sales 2024
0.42x
EV / Sales 2025 0.95x
Free-Float
92.21%
Yield 2024 *
-
Yield 2025 -
1 day+6.98%
1 week+14.06%
Current month-9.88%
1 month-2.67%
3 months-36.34%
6 months-50.23%
Current year-64.33%
1 week 0.02
Extreme 0.017
0.03
1 month 0.02
Extreme 0.017
0.03
Current year 0.02
Extreme 0.015
0.1
1 year 0.02
Extreme 0.015
0.1
3 years 0.02
Extreme 0.015
0.1
5 years 0.02
Extreme 0.015
0.36
10 years 0.02
Extreme 0.015
9.2
Manager TitleAgeSince
Chief Executive Officer 68 31/05/2018
Director of Finance/CFO 51 15/03/2019
Director TitleAgeSince
Director/Board Member 68 31/05/2018
Director/Board Member 56 21/07/2022
Director/Board Member 58 21/10/2022
Date Insider Type Main position Quantity % Market Cap.
18/02/25 Free

Chief Executive Officer

3,000,000 1.6281%
18/02/25 Free

Chief Financial Officer

2,350,000 1.2753%
18/02/25 Free

Director

500,000 0.2714%
Change 5-day change 1-year change 3-year change Capi.($)
+6.98%+14.06%-44.84%-55.58% 4.18M
+1.97%+2.53%+52.73%+156.66% 1,037B
+1.42%+4.96%+54.39%+52.34% 615B
+1.43%+5.25%+37.31%+78.74% 448B
+5.14%+5.84%+37.54%+27.28% 326B
+1.85%+4.64%+38.53%+39.87% 293B
-0.11%+0.97%+22.57%+17.81% 264B
+0.25%-3.10%-24.44%-42.25% 216B
+1.49%+3.68%+21.53%+58.21% 198B
+0.40%-0.64%+18.78%+62.28% 162B
Average +2.08%+1.69%+21.41%+39.54% 355.74B
Weighted average by Cap. +1.73%+1.47%+38.33%+75.23%

Financials

2024 2025
Net sales 15.7M 13.81M 12.83M 11.8M 22.13M 1.52B 22.53M 153M 59.85M 742M 58.96M 57.68M 2.57B 13.79M 12.13M 11.27M 10.36M 19.43M 1.34B 19.78M 135M 52.55M 651M 51.77M 50.65M 2.26B
Net income -2.39M -2.11M -1.96M -1.8M -3.37M -232M -3.43M -23.39M -9.12M -113M -8.99M -8.79M -392M -958K -843K -783K -720K -1.35M -92.77M -1.37M -9.36M -3.65M -45.25M -3.6M -3.52M -157M
Net Debt 325K 286K 266K 244K 458K 31.47M 466K 3.18M 1.24M 15.35M 1.22M 1.19M 53.26M 1.72M 1.51M 1.4M 1.29M 2.42M 166M 2.46M 16.79M 6.55M 81.15M 6.45M 6.31M 282M
Logo CV Sciences, Inc.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Employees
43
Date Price Change Volume
23/07/26 $0.0219 +6.98% 497,296
22/07/26 $0.0205 +3.39% 305,777
21/07/26 $0.0198 +10.00% 525,767
20/07/26 $0.0180 -10.00% 528,130
17/07/26 $0.0200 -2.44% 1,039,549
  1. Stock Market
  2. Stocks
  3. CVSI Stock